Leo A. J. Kluijtmans

Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.

Leo A. J. Kluijtmans, Lambertus P. van den Heuvel, G. H. J. Boers et al. · PubMed · 1996 · 660 citations · Full text

FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study

Anu Suomalainen, Jenni M. Elo, Kirsi H. Pietiläinen et al. · The Lancet Neurology · 2011 · 414 citations · Full text

Diagnostic Study, Fibrosis, Mitochondrial Function +3

Exome Sequencing and the Management of Neurometabolic Disorders

Maja Tarailo‐Graovac, Casper Shyr, Colin J.D. Ross et al. · New England Journal of Medicine · 2016 · 274 citations · Full text

The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations

Derval J. Gaughan, Leo A. J. Kluijtmans, Sandrine Barbaux et al. · Atherosclerosis · 2001 · 272 citations

Biochemistry, Plasma Homocysteine Concentrations, Genetics +9

Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults

Leo A. J. Kluijtmans, Ian Young, Colin Boreham et al. · Blood · 2003 · 243 citations